Literature DB >> 22651218

Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.

Jonas H Fagerberg1, Yassir Al-Tikriti, Gert Ragnarsson, Christel A S Bergström.   

Abstract

Ethanol intake can lead to an unexpected and possibly problematic increase in the bioavailability of druglike compounds. In this work we investigated the effect of ethanol on the apparent solubility and dissolution rate of poorly soluble compounds in simulated intestinal fluid representing a preprandial state. A series of 22 structurally diverse, poorly soluble compounds were measured for apparent solubility and intrinsic dissolution rate (37 °C) in phosphate buffer pH 6.5 (PhB6.5) and fasted state simulated intestinal fluid (FaSSIF, pH 6.5) with and without ethanol at 5% v/v or 20% v/v. The obtained data were used to understand for which molecules ethanol results in an increased apparent solubility and, therefore, may increase the amount of drug absorbed. In FaSSIF20%ethanol 59% of the compounds displayed >3-fold higher apparent solubility than in pure FaSSIF, whereas the effects of 5% ethanol on solubility, in most cases, were negligible. Acidic and neutral compounds were more solubilized by the addition of ethanol than by lecithin/taurocholate aggregates, whereas bases showed a more substance-specific response to the additives in the buffer. The stronger solubilizing capacity of ethanol as compared to the mixed lipid aggregates in FaSSIF was further identified through Spearman rank analyses, which showed a stronger relationship between FaSSIF20%ethanol and PhB6.5,20%ethanol (rS of 0.97) than FaSSIF20%ethanol and FaSSIF (rS of 0.86). No relationships were found between solubility changes in media containing ethanol and single physicochemical properties, but multivariate data analysis showed that inclusion of ethanol significantly reduced the negative effect of compound lipophilicity on solubility. For this data set the higher concentration of ethanol gave a dose number (Do) <1 for 30% of the compounds that showed incomplete dissolution in FaSSIF. Significant differences were shown in the melting point, lipophilicity, and dose profiles between the compounds having a Do < 1 and Do > 1, with the latter having higher absolute values in all three parameters. In conclusion, this study showed that significant effects of ethanol on apparent solubility in the preprandial state can be expected for lipophilic compounds. The results herein indicate that acidic and neutral compounds are more sensitive to the addition of ethanol than to the mixed lipid aggregates present in the fasted intestine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22651218     DOI: 10.1021/mp2006467

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  15 in total

1.  Computational prediction of drug solubility in lipid based formulation excipients.

Authors:  Linda C Persson; Christopher J H Porter; William N Charman; Christel A S Bergström
Journal:  Pharm Res       Date:  2013-06-15       Impact factor: 4.200

2.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.

Authors:  Hywel D Williams; Philip Sassene; Karen Kleberg; Marilyn Calderone; Annabel Igonin; Eduardo Jule; Jan Vertommen; Ross Blundell; Hassan Benameur; Anette Müllertz; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-05-10       Impact factor: 4.200

3.  Computational prediction of drug solubility in fasted simulated and aspirated human intestinal fluid.

Authors:  Jonas H Fagerberg; Eva Karlsson; Johan Ulander; Gunilla Hanisch; Christel A S Bergström
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

Review 4.  Computational prediction of drug solubility in water-based systems: Qualitative and quantitative approaches used in the current drug discovery and development setting.

Authors:  Christel A S Bergström; Per Larsson
Journal:  Int J Pharm       Date:  2018-02-06       Impact factor: 5.875

5.  Impact of Magnesium Stearate Presence and Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties.

Authors:  P Zarmpi; T Flanagan; E Meehan; J Mann; Nikoletta Fotaki
Journal:  AAPS J       Date:  2020-05-21       Impact factor: 4.009

6.  Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC).

Authors:  P Zarmpi; T Flanagan; E Meehan; J Mann; N Fotaki
Journal:  AAPS J       Date:  2020-02-18       Impact factor: 4.009

7.  Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose.

Authors:  Sachiko Fukui; Hideki Yano; Shuichi Yada; Tsuyoshi Mikkaichi; Hidemi Minami
Journal:  Asian J Pharm Sci       Date:  2016-11-18       Impact factor: 6.598

8.  Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties.

Authors:  Deanna M Mudie; Nasim Samiei; Derrick J Marshall; Gregory E Amidon; Christel A S Bergström
Journal:  AAPS J       Date:  2020-01-27       Impact factor: 4.009

9.  Tools for Early Prediction of Drug Loading in Lipid-Based Formulations.

Authors:  Linda C Alskär; Christopher J H Porter; Christel A S Bergström
Journal:  Mol Pharm       Date:  2015-12-07       Impact factor: 4.939

10.  Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants.

Authors:  Panagiota Zarmpi; Talia Flanagan; Elizabeth Meehan; James Mann; Nikoletta Fotaki
Journal:  AAPS J       Date:  2020-02-11       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.